Bowery Raises USD 50 Million in Series B, Opens Third Farm in Baltimore

The new farm will be 3.5 times larger than Bowery's previous facility. The network of farms communicates using Bowery's software and benefits from the collective intelligence of more than two years of data. The company's proprietary software system, BoweryOS, makes use of vision systems, automation technology, and machine learning to monitor plants continuously and all the variables that drive their growth.

FREMONT, CA: New York-based indoor farming startup Bowery raised USD 50 million in a Series B funding round led by Temasek and participation from Henry Kravis, co-founder of Kohlberg Kravis Roberts & Co. The funding comes in 11 months after the startup raised USD 90 million in a Series A funding round. With the new funding, the company's total raised capital stands at USD 172.5 million since its inception in 2015.

Bowery is also set to open its third farm in the Baltimore DC area. According to the company, the new farm will be 3.5 times larger than Bowery's previous facility. The network of farms communicates using Bowery's software and benefits from the collective intelligence of more than two years of data. The company's proprietary software system, BoweryOS, makes use of vision systems, automation technology, and machine learning to monitor plants continuously and all the variables that drive their growth.

Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.

According to the company, Bowery farms use zero pesticides and 95 percent less water as the entire process from seed to storage is controlled by the company. They believe this method is much more productive on the same footprint of land than traditional agriculture. "The company is focused on creating scalable solutions for an impending climate and food crisis, and we deeply believe in the power of technology to make drastic, necessary improvements to the food system,” said Irving Fain, Co-founder, and CEO, Bowery.

The Singapore based investment firm Temasek had participated in a USD 70 million Series B funding in Pivot Bio, a US agriculture startup that combines machine learning and computational modeling to help microbes in providing plants with a daily supply of nitrogen, eliminating pollution in the process. The funding round was led by Breakthrough Energy Ventures. “We are excited to share that Bowery’s third (and biggest) farm yet is launching in the DC-Baltimore area in early 2020. Along with this expansion, our team is elated to announce an additional $50 million in funding led by Temasek that will drive further innovation and scale across our organization,” the company said in a statement.

More in News

The biotech sector is experiencing a significant surge, with funding increasing rapidly. The growth is expected to continue in the coming years as investors, professionals, and consumers seek more profound insights into the industry. The effects of the pandemic have further accelerated investments in this field. Key trends shaping the biotech landscape include the diversification of patent portfolios and substantial capital investments from companies, which often aim for short to mid-term gains. Recent developments have propelled the biotech industry to new heights, potentially paving the way for further market maturation in the future. The strengthened ties between the biotech and R&D model thrives a possible income through the sector and are becoming investors' subject of interest in recent times. As the investments owing to the biotech companies began exceeding 148 per cent, biotech companies are gaining crucial popularity in the domain of an effective biopharmaceutical service. That is, the pharmaceutical companies and the treatments and drugs they manufacture are well known to the public, with solo investors and venture capital firms allocating their resources for quality-based and larger investments. However, a thick difference between the biotech and tech genres exists, making each potentially stable in its sectors. Biotech startups share similar characteristics to that of a general startup system where it requires delicate effort and conditions for a Minimum Viable Product (MVP) in a short time and is yet to attain a high-efficacy rate. Meanwhile, the risks available in structuring a biotech company can be challenging owing to the increased sum of investments, needs, and funds for the research and development of a drug along with the regulatory approvals. It is these factors that determine the time required for a product to reach the market for significant revenue growth. Setting up a biotech startup can be relatively onerous owing to the high level of technical risks that are generally involved with the development of a drug. In addition, reimbursement policies may often result in the decoupling of end-users (patients) and payees. However, their security often relies on the patent and market exclusivity periods where early-stage trials are essential for improving drug efficacy. Despite adhering to research and development programs, biotech startups frequently encounter setbacks from the Food and Drug Administration and other regulatory agencies. They generate pre-revenues for venture capital (VC) backing in startup investments. Therefore, it is essential to consider these varying factors for the effective setup of biotech startups globally that could satisfy VC investments. ...Read more
Texas has emerged as a vibrant hub for tech startups, propelled by a unique combination of resources, opportunities, and innovation-friendly policies. The rapid growth of tech startups can be attributed to several critical factors, including a thriving entrepreneurial ecosystem, access to funding, a skilled workforce, a favorable business climate, and strategic geographic advantages. The elements have transformed Texas into a destination for entrepreneurs looking to scale their tech ventures. Access to venture capital and funding opportunities has been another critical growth driver. The primary growth factor for tech startups in Texas is the state's thriving entrepreneurial ecosystem. Cities like Austin, Dallas, Houston, and San Antonio have become hotbeds for innovation, offering startups access to a dynamic network of accelerators, incubators, and coworking spaces. Local organizations provide mentorship, networking, and resources tailored to the needs of early-stage companies, creating an environment where startups can thrive. Texas ranks among the top states in the U.S. for venture capital investment, with investors increasingly recognizing the potential of startups in sectors such as software, biotech, energy, and artificial intelligence. Texas-based angel investors and crowdfunding platforms provide alternative funding options, empowering entrepreneurs to secure the capital needed for expansion. Public-private partnerships further bolster financial support for high-tech innovation, particularly in early-stage development. The state's robust educational infrastructure, including top-tier institutions, produces a steady stream of talent in STEM fields. Many institutions engage with startups through research collaborations, technology transfer programs, and entrepreneurship initiatives. Texas' pro-business environment has played a pivotal role in the success of its tech startups. The absence of a state income tax and relatively low regulatory burdens make Texas an attractive place to start and grow a business. The state government actively supports entrepreneurship through policies that encourage innovation and investment. Economic development programs, such as tax incentives and grants for small businesses, further motivate entrepreneurs to set up operations in Texas. Geographic and industrial diversity further contribute to the growth of Texas tech startups. The state's central location offers logistical advantages for companies with national or global markets. Texas' economic landscape spans industries like energy, healthcare, manufacturing, and agriculture, creating opportunities for startups to innovate across various sectors. Its well-developed infrastructure, including major airports and shipping routes, supports supply chain efficiency. Large enterprises based in the state increasingly partner with startups to co-develop technologies or integrate innovative solutions. The partnerships provide startups with industry expertise, resources, and market opportunities, accelerating their growth trajectory. ...Read more
Startups are seeing a significant change in the workplace due to changing business models, workforce demands, and technology breakthroughs. Previously characterized by conventional office settings and inflexible work arrangements, startups are already adopting more adaptable, creative methods for determining where and how work is completed. The startup culture is changing due to remote work, hybrid teams, and digital communication tools. These innovations enable businesses to access worldwide talent pools and promote a more flexible and inclusive workplace. In an increasingly competitive market, companies' success will depend on their capacity to manage these shifts and prioritize employees' productivity, creativity, and well-being as they grow.  The Evolving Landscape of Work in Startups Remote Work and Digital Nomadism The rise of remote work has expanded opportunities for startups to access a global talent pool. As more companies adopt fully remote models, digital nomadism has gained traction, allowing individuals to work from anywhere while exploring the world. This shift has reshaped traditional work structures and contributed to a more flexible, location-independent workforce. Flexible Work Arrangements Flexibility has become a central element of modern startup culture. Companies are experimenting with various work arrangements, such as flexible hours, job-sharing, and part-time contracts, to determine what best enhances productivity and work-life balance. The focus is on creating environments that prioritise personal time and foster creativity, acknowledging that flexibility can drive long-term innovation. The Gig Economy Startups are increasingly relying on freelance and contract workers to manage project-based tasks. This trend allows businesses to access diverse skills on demand, enabling them to scale quickly and efficiently. By tapping into the gig economy, startups can remain agile, responding to specific needs without the long-term commitments associated with traditional hiring models. Employee Ownership and Equity Many startups have become famous for incentivising employees through stock options and equity. This model fosters a sense of ownership and partnership, motivating individuals to invest in the company's long-term success. By offering equity as part of compensation packages, startups are encouraging employee commitment and aligning personal and organisational goals. Innovation in Hiring Practices To attract top talent, startups are rethinking their hiring practices. Emphasis is shifting from traditional credentials to qualities such as problem-solving abilities and cultural fit. Innovative approaches like AI-powered candidate screening and gamified assessments are being integrated into recruitment processes, helping startups identify candidates who align with their values and needs. Emphasis on Diversity and Inclusion Startups increasingly prioritise diversity and inclusion, recognising its role in driving innovation. By fostering inclusive work environments, startups aim to attract diverse perspectives and ideas. This focus on diversity extends to recruitment strategies, policies, and creating a workplace culture that values different backgrounds and experiences. Learning and Development As technological change accelerates, continuous learning has become a critical component of the startup environment. Companies are investing in employee development by offering access to online courses, workshops, and conferences. Encouraging ongoing learning helps employees stay current with industry trends and enhances their skill sets, supporting individual growth and organisational success. Wellness and Mental Health Startups are increasingly emphasising employee wellness and mental health, recognising the high demands and stress that often accompany startup life. Companies are offering benefits such as gym memberships, mental health days, and wellness programs to support the well-being of their teams. Focusing on mental health helps create a more sustainable work environment, enabling employees to perform at their best while maintaining a healthy work-life balance. The startup ecosystem is redefining the future of work by embracing flexibility, diversity, and continuous learning. These trends are shaping how startups operate and influencing broader corporate practices. As these changes continue to evolve, they have the potential to reshape global employment trends and the overall approach to work across industries. ...Read more
With a monumental increase in funding by 39.6 per cent, the biotech market is anticipated to escalate incredibly in the upcoming years with the investors, workers, and consumers of the sector reaching out for greater insights. Additionally, the after-effects of the pandemic are accelerating the investment scale in the sector. Hence, the trends that reshape the biotech industry generally encompass diversification of patent production and maximum capital investments by the enterprises for a favourable outcome that is mostly short-lived or mid-term. In particular, recent years have contributed to the biotech industry’s peak level and will probably favour a wide maturation of the market in the later periods. The strengthened ties between the biotech and R&D model thrives a possible income through the sector and are becoming investors' subject of interest in recent times. As the investments owing to the biotech companies began exceeding 148 per cent, biotech companies are gaining crucial popularity in the domain of an effective biopharmaceutical service. That is, the pharmaceutical companies and the treatments and drugs they manufacture are well known to the public, with solo investors and venture capital firms allocating their resources for quality-based and larger investments. However, a thick difference between the biotech and tech genres exists, making each potentially stable in its sectors. Biotech startups share similar characteristics to that of a general startup system where it requires delicate effort and conditions for a Minimum Viable Product (MVP) in a short time and is yet to attain a high-efficacy rate. Meanwhile, the risks available in structuring a biotech company can be challenging owing to the increased sum of investments, needs, and funds for the research and development of a drug along with the regulatory approvals. It is these factors that determine the time required for a product to reach the market for significant revenue growth. Setting up a biotech startup can be relatively onerous owing to the high level of technical risks that are generally involved with the development of a drug. In addition, reimbursement policies may often result in the decoupling of end-users (patients) and payees. However, their security often relies on the patent and market exclusivity periods where early-stage trials are essential for improving drug efficacy. Despite adhering to research and development programs, biotech startups frequently encounter setbacks from the Food and Drug Administration and other regulatory agencies. Furthermore, they generate pre-revenues for venture capital (VC) backing in startup investments. Therefore, it is essential to consider these varying factors for the effective setup of biotech startups globally that could satisfy VC investments. ...Read more

Weekly Brief